The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

The agency approved the drug based on data from the DESTINY-Breast06 trial, which included patients who had tumors with very low HER2 expression.

New approval brings the medicine to an earlier treatment setting and a broader patient population.

Hollywood power couple Blake Lively and Ryan Reynolds are being targeted in a US$400 million (S$546.6 million) defamation suit by Justin Baldoni, Lively's co-star on bleak romance It Ends With Us – ...

Justin Baldoni has sued Blake Lively and her husband Ryan Reynolds, alleging that the Hollywood couple sought to “destroy” him and his career, after hijacking his film, “It Ends With Us.” ...

Suits ' Gabriel Macht Reveals He and His Family Moved Out of the U.S.

1 Day DSKYF 10.11% DJIA 1.65% S&P 500 1.83% Health Care/Life Sciences 0.69% ...

The actor-director has accused his "It Ends With Us" costar and her husband of hijacking the film and destroying his reputation. He is requesting at least $400 million in damages. Jessica is a ...

Justin Baldoni, 40, is suing Blake Lively, Ryan Reynolds, their publicist Leslie Sloane and Sloane’s p.r. firm Vision PR Inc. over the continued drama of “It Ends With Us.” Baldoni’s ...

"It Ends With Us" actor and director Justin Baldoni has sued his co-star Blake Lively and her husband, "Deadpool" actor Ryan Reynolds, for defamation on Thursday in the latest step in a bitter ...